Position in NUVB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,343,882
+$449,651 QoQ
Shares Held
1,116,881
-18.7% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 242 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Derivatives in NUVB
reported options exposure · as of Jun 30, 2026CallValue
$36,208,324
CallShares
6,374,705
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. NUVB ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in NUVB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,208,324 | 6,374,705 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $6,343,882 | 1,116,881 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,894,231 | 1,373,947 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,514,001 | 615,402 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,359,972 | 908,101 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $924,181 | 473,939 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,534,177 | 871,692 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,922,843 | 1,850,693 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,065,099 | 465,109 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,166,782 | 399,583 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,542,639 | 423,802 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $575,791 | 381,319 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $128,112 | 95,606 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $171,577 | 95,321 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $183,187 | 110,354 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $12,588 | 5,620 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,410 | 2,596 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $189 | 36 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,326 | 509 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $864 | 87 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $623 | 67 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $21,558 | 2,063 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||